Context Current management of patients with unstable angina and non-Q wave myocardial infarction generally consists of intensive medical therapy, with angiography and revascularization sometimes limited to those who fail such therapy.
Introduction
The Thrombolysis in Myocardial Ischemia (TIMI) IIIB study investigated the role of two management strategies and the use of a thrombolytic agent in patients with unstable angina pectoris and non-Q wave myocardial infarction. TIMI IIIB demonstrated that although there was no difference in mortality or occurrence of myocardial infarction after study entry between an early invasive strategy (early coronary arteriography followed by revascularization when the anatomy was suitable) and an early conservative strategy (coronary arteriography followed by revascularization if initial medical therapy failed), the early invasive strategy was more efficient in resource utilization: patients randomized to the early invasive strategy had a shorter length of initial hospitalization (P=0·01), less frequent re-hospitalization within 6 weeks (P<0·001), fewer days of re-hospitalization within 6 weeks (P<0·001), and less use of antianginal medications after discharge [1] . Risk-stratifying tests (exercise treadmill test, stress thallium-201 scintigraphy, and 24 h Holter monitoring) were performed during hospitalization to identify the presence of residual ischaemia, and if these tests were markedly abnormal, or if ischaemia occurred spontaneously, patients were considered to have 'failed initial therapy' and, if assigned to the early conservative strategy, underwent coronary angiography and revascularization if their coronary anatomy was suitable, in accord with contemporary practice guidelines [2] . It would be desirable to be able to identify on admission those patients with unstable angina or non-Q wave myocardial infarction most likely to die or develop myocardial infarction, spontaneous ischaemia, or a markedly positive risk stratifying test so that one could direct them expeditiously to an invasive strategy in a cost effective manner. Many patients with unstable angina are cared for in institutions in which coronary angiography is not available and guidelines would be useful to identify appropriate patients for transport to a facility to undergo angiography and to hold others for more conservative medical management. The purpose of this database study, therefore, was to determine if it is possible to predict from baseline characteristics those who would or would not 'fail' initial therapy (as defined above).
Methods

Patient population
The study cohort consists of the patients in TIMI IIIB randomly assigned to the conservative strategy. The TIMI IIIB study has been described previously [1] . In brief, patients were eligible for study participation if they experienced chest discomfort at rest that was judged to be caused by myocardial ischaemia and that lasted d5 min, but c6 h. In addition, the discomfort must have occurred within 24 h of enrolment and have been accompanied by objective evidence of ischaemic heart disease. The latter consisted of either (1) new or presumably new ECG evidence of ischaemia in at least two contiguous leads (d0·1 mV ST segment elevation lasting <30 min, transient or persistent c0·1 mV ST segment depression, or T-wave inversion during an episode of rest pain within the prior 7 days) or (2) documented coronary artery disease (a history of previous myocardial infarction or a c70% luminal diameter stenosis on a previous coronary arteriogram or a positive exercise thallium scintigram).
Management
All patients were to be treated with conventional medical therapy for unstable angina: bed rest, oxygen, and anti-ischaemic therapy consisting of metoprolol 50 mg orally every 12 h, diltiazem 30 mg orally every 6 h, and a long-acting nitrate (isosorbide dinitrate 10 mg orally every 8 h, or larger doses) and supplemented by sublingual nitroglycerin whenever necessary. Intravenous nitroglycerin was given at the discretion of the treating physician. Patients were to receive a 5000 IU intravenous bolus of heparin and a continuous maintenance infusion adjusted to keep the activated partial thromboplastin time at 1·5 to 2·0 times laboratory control values. A small number of patients were already hospitalized and on heparin at the time of their qualifying episode of rest angina, and in these patients the maintenance heparin infusion was adjusted as noted above. Aspirin 325 mg daily was to begin on the second day. After hospital discharge, patients were to be managed with anti-ischaemic medical therapy and aspirin 325 mg four times a day.
Randomization
Patients were randomly assigned to an early invasive or early conservative strategy as well as to treatment with front-loaded tissue type plasminogen activator or placebo (2 2 factorial design). The mean dose of tissue type plasminogen activator was 63 mg. No treatment effect was observed for tissue type plasminogen activator vs placebo; all patients in the early conservative strategy are consequently considered together.
Early invasive strategy
Patients assigned to the early invasive strategy were to undergo coronary angiography and left ventricular angiography 18 to 48 h after randomization. Revascularization was to be performed if the anatomy was suitable. These patients are not included in the current study.
Early conservative strategy
Patients randomized to the early conservative strategy were treated medically unless they 'failed' medical
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therapy, defined as the development of recurrent rest ischaemia with ST-segment depression (i.e. chest discomfort at rest that was judged to be caused by myocardial ischaemia), recurrent myocardial infarction, or an abnormal result on a risk-stratifying test. If such evidence of ischaemia developed, the patients were required to undergo cardiac catheterization and coronary angiography. The following outcomes were considered as failure of medical therapy: clinical event: (1) a single episode of ischaemic discomfort at rest lasting d5 min with d0·2 mV ST-segment elevation or depression in two contiguous ECG leads; or (2) a single episode of ischaemic pain at rest lasting d20 min or two or more separate episodes of ischaemic pain at rest, each lasting d5 min, associated with d0·1 mV ST-segment depression; or (3) after hospital discharge the recurrence of unstable angina with rest pain sufficient to require rehospitalization; or a very abnormal risk stratifying test: (1) >20 min of ischaemic ST-segment deviation (d0·1 mV) on the 24-h Holter monitor recording; (2) an unsatisfactory result on the pre-discharge stress thallium exercise treadmill test before completion of stage II of a modified ('low-level') Bruce protocol: an unsatisfactory result was defined as (a) the occurrence of ischaemic discomfort, (b) d0·2 mV ischaemic ST-segment deviation, or (c) a reduction in systolic pressure >10 mmHg based on two determinations, (d) significant abnormalities in the thallium scintigram defined as two or more regions with reversible hypoperfusion or increased lung uptake with one region of reversible hypoperfusion.
Patients randomized to the early conservative strategy who developed recurrent ischaemia with ST-segment depression or an abnormal test on initial therapy and therefore had catheterization were subsequently managed in a manner similar to those in the early invasive strategy.
Exercise treadmill tests were performed using the modified Bruce protocol within 3 days prior to, or up to 5 days after, hospital discharge and were interpreted at the Rest and Exercise ECG Core Laboratory. For those who could not exercise, cardiac stress was induced using dipyridamole (0·142 mg . kg 1 . min 1 infusion over 4 min). Thallium-201 stress tests were performed as part of the exercise treadmill test and were read in the Thallium Test Core Laboratory. Holter monitoring was performed for 24 h between days 2-5 after randomization using modified V 5 and modified aVF leads and were analysed at the Holter Analysis Core Laboratory.
Event classification
All reported recurrent myocardial infarctions were reviewed and classified by the Mortality and Morbidity Classification Committee [1] .
Statistical methods
'Failure of medical therapy' was defined as either the development of a clinical event (death, myocardial infarction, or rest angina with ST-segment depression by 6 weeks follow-up), or a very abnormal risk-stratifying test as described above. A test profile of descending order of severity was defined for each test indicating whether the patient had an ischaemic event (death, myocardial infarction, or rest angina with ST-segment depression) prior to the test, whether the test showed a marked abnormality (as defined above), or no abnormality. For the exercise treadmill test, a 'no test' category was included since 51 patients did not perform an exercise test. This no test category for the exercise test was inserted in order of severity just below 'previously declared ischaemia' because patients in TIMI II who could not perform the exercise test had a higher percentage of serious clinical events than those who performed the exercise test, even those who had a positive test [3] . A similar analysis suggested this was also the case among the TIMI IIIB patients. When we examined the occurrence of clinical events for 'test not done' for the thallium test and the Holter, in contrast, the occurrence of subsequent clinical events was lower than for patients who performed the test. Thus, for the thallium and the Holter tests, 'no test done' was grouped with a negative test.
Student's t-test, analysis of variance, or a chi-square statistic depending on the nature of the baseline characteristic, and the dimension of the profile variable were used to compare the distribution of the baseline characteristics across the different levels of a specified profile variable.
Each baseline variable determined to be associated with an outcome profile was included in a multiple logistic regression with the ordered profile variable serving as the dependent variable. A stepwise logistic regression was performed to identify those baseline variables with independent associations with the outcome profile. The odds ratios reported indicate whether the baseline variable increased the probability of a more severe response (a positive coefficient) or if it decreased the probability of a more severe response (negative coefficient). All independent variables found to be clinically and statistically significant in the analysis of any test profile were then included in a final set of regressions for each of the test profiles. This set of key variables was used to count the number of key risk characteristics present in each patient.
All of the analyses presented here represent secondary analyses. Accordingly, P-values <0·01 were considered to show some evidence of an association between the dependent variable, and the independent variable(s), and P-values <0·001 were considered to show strong evidence of an association.
Results
Patient population
Seven hundred thirty-three patients were randomized to the early conservative strategy in TIMI IIIB and are included in this study. Their baseline characteristics are displayed in Table 1 . Seventy-five percent of the patients presented with ECG changes, 40% had a history of a previous myocardial infarction, and one third had a previous coronary angiogram showing critical obstruction.
Prediction of death, myocardial infarction, or rest ischaemia by 6 weeks
Two hundred and forty-one patients (33%) died, or developed a myocardial infarction or ischaemia at rest with ST-segment depression by 6 weeks after randomization and 173 additional patients (24%) developed a markedly abnormal risk-stratifying test (Table 2) . On univariate analysis these 414 (241+173) patients who developed a clinical event or markedly abnormal test were significantly older, more likely to have a history of prior exertional or accelerating angina, had received treatment with calcium-channel blockers, tended to receive treatment with heparin, nitrates and betaadrenergic blockers in the week prior to randomization, more frequently presented with new (or presumably new) ST-segment depression and were less likely to have T-wave changes on the qualifying ECG compared to the 319 patients in whom these events did not occur. There was no difference in the outcome at 42 days between those patients who initially presented with unstable angina compared to those who initially presented with non-Q wave myocardial infarction. In Cox proportional hazard regression analysis of the six key baseline characteristics identified in this study the following were independently predictive of a cardiac event (Table 3) : ST-segment depression on the qualifying ECG, prior use of heparin, prior use of aspirin, and older age. By combining the independent baseline risk characteristics, the incidence of a clinical end-point ranged from 8% if no risk characteristics were present to 63% if all six were present (Fig. 1) Fig. 2 . Logistic regression analysis of the six key variables identified in this study indicated that the following baseline characteristics were each independently predictive of the development of a clinical event prior to the test or an abnormal exercise test (Table 3) : ST-segment depression on the initial ECG associated with the qualifying episode of angina, a family history of premature coronary artery disease (i.e. onset <55 years of age), prior use of heparin or aspirin, and older age. By combining the independent baseline risk characteristics, the incidence of developing a clinical end-point or a markedly abnormal exercise test outcome ranged from 21% if none of the risk characteristics were present to 88% if all of these predictive characteristics were present (Fig. 1) .
Prediction of an abnormal thallium test response or death, myocardial infarction, or rest ischaemia occurring prior to thallium test
Nineteen patients (3%) did not perform the stress thallium test and 390 (53%) had no abnormality or only a mild abnormality. One hundred and sixty-three patients (22%) exhibited a marked abnormality, and 161 (22%) died, or developed myocardial infarction, or rest ischaemia with ST-segment depression prior to the test. Logistic regression analysis of the six key variables identified in this study indicated that the following variables were independently associated with a significantly increased likelihood of a clinical event prior to the test or an abnormal test: ST-segment depression on the 
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initial ECG associated with the qualifying episode of angina, prior history of angina, prior use of heparin or aspirin, and older age (Table 3) . By combining the baseline risk characteristics, the incidence of developing a markedly abnormal thallium outcome or a clinical end-point to the test ranged from 21% if none were present to 75% if all risk characteristics were present (Fig. 1) .
Prediction of an abnormal Holter response or death, myocardial infarction, spontaneous ischaemia occurring prior to the Holter test
Eleven patients (2%) did not perform the Holter and 576 (78%) exhibited either no ischaemic episodes or <20 min of ischaemia during the test. Twenty-six patients (4%) exhibited a marked abnormality, and 120 (16%) died or developed a myocardial infarction or rest ischaemia with ST-segment depression prior to the test. Logistic regression analysis of the six key variables identified in this study indicated that the following variables were independently associated with an increased likelihood of a clinical event prior to the test or a markedly abnormal Holter: ST-segment depression on the qualifying ECG associated with angina, prior use of heparin and older age (Table 3) . By combining the baseline risk characteristics, the incidence of developing an abnormal Holter outcome or a clinical end-point ranged from 8% if none were present to 50% if all risk characteristics were present.
Unique prognostic contribution of each risk-stratifying test
Of the 199 patients in whom a risk-stratifying test was markedly positive in the absence of rest ischaemia, the high risk was uniquely identified by the thallium test in 34% of the patients, by the exercise test in 33%, and by the Holter in only 3%. Seventy-three (23%) of 316 patients with a negative or mildly abnormal exercise test and no in-hospital ischaemia nevertheless developed a markedly abnormal test result on one of the other risk-stratifying tests. Similarly, 66 (21%) of 317 patients with a negative or mildly abnormal thallium test and 186 (43%) of 429 patients with a negative or mildly abnormal Holter developed a markedly abnormal test result on one of the other risk-stratifying tests.
Discussion
The current management of patients with unstable angina or non-Q wave myocardial infarction generally consists of bed rest, aspirin, heparin, and the rapid escalation of anti-anginal therapy. A majority of patients become clinically stable with such therapy, and angiography and revascularization are generally reserved for those who either develop recurrent clinical evidence of ischaemia despite maximum medical therapy or who exhibit evidence of marked ischaemia on riskstratifying tests routinely performed prior to discharge. This study identifies patient baseline characteristics which can be used to predict an increased likelihood of subsequently developing ischaemia during the hospitalization: ST-segment depression on the qualifying ECG, prior history of angina, family history of premature coronary disease, development of the qualifying episode of acute ischaemia despite use of heparin or aspirin, and older age. With use of these characteristics it may be possible to identify patients who are likely to fail continued medical therapy and initiate a more expedited strategy of invasive catheterization and revascularization in a more cost-effective manner.
Use of an abnormal risk stratifying test or spontaneous ischaemia early in the course of unstable angina and non-Q wave myocardial infarction as a surrogate for an unfavourable cardiac outcome
The development of an abnormal risk-stratifying test or rest ischaemia is known to be an important predictor of an adverse cardiac outcome in patients with unstable angina and non-Q wave myocardial infarction, and thus may serve as an appropriate surrogate for that adverse outcome. In this TIMI IIIB database study the presence of an abnormal test result serves as a surrogate of the adverse cardiac outcome because the presence of an abnormal test result or rest ischaemia by itself led, according to the protocol, to the performance of urgent coronary angiography and revascularization. The expected natural history associated with an abnormal test result, therefore, was altered by the intervention required by the protocol. Thus, although the prognostic significance of an abnormal risk stratifying test or rest ischaemia with ST-segment depression could not be determined in the TIMI IIIB, the clinical variables that predict those patients who have serious test profiles could be investigated. Use of abnormalities detected on risk stratifying tests as a surrogate for an adverse clinical event is justified on the basis of extensive experience with the three tests used in TIMI IIIB: the exercise test, thallium perfusion scintigraphy, and the Holter monitor. Nyman et al. [4] found that the presence of d0·1 mV ST-segment depression on a pre-discharge exercise test in 740 men hospitalized with unstable angina or non-Q wave myocardial infarction was associated with an 18% incidence of myocardial infarction or death after 1 year follow-up, compared to 9% in patients without exertional ST-segment depression. Krone et al. [5] demonstrated that the presence of ST-segment depression d0·1 mV on a pre-discharge exercise test in patients with a first non-Q wave myocardial infarction experienced a more than threefold increase in the incidence of cardiac death or recurrent non-fatal myocardial infarction compared to those without ST depression (24% vs 7%; P=0·026), and that the predictive value was particularly useful in those patients with clinical markers of increased risk.
Stress thallium-201 perfusion scintigraphy, generally performed in combination with the exercise treadmill test, has been reported to provide even more prognostic information than exercise-induced ST-segment changes in patients stabilized following unstable angina or non-Q wave myocardial infarction [6] [7] [8] [9] . Marmur et al. [7] found that the size of a reversible thallium-201 defect identified 5 2 days after admission for unstable angina correlated with the likelihood of cardiac events within 6 months in patients without prior myocardial infarction. Amanullah et al. [10] observed that both exertional ST-segment depression and reversible thallium defects were univariate predictors of the development of nonfatal myocardial infarction or revascularization within 30 months of hospitalization for unstable angina, but that only the presence of a reversible perfusion defect remained significant in a multivariate logistic regression analysis.
Episodes of ST-segment deviation, which are usually asymptomatic, recorded during Holter monitoring performed within the first few days of hospitalization with unstable angina are associated with an increased risk of developing an adverse cardiac event [11] [12] [13] [14] . Prior to the routine use of heparin and aspirin in the treatment of unstable angina the incidence of episodes of ST-segment deviation was reported to be as high as 72%, while the incidence of such episodes in patients treated with anticoagulant and antiplatelet therapy has often been substantially lower [15] . The presence of spontaneous chest pain following stabilization of an acute ischaemic syndrome has been associated with a poor outcome [16] [17] [18] [19] , especially if it is accompanied by reversible ST-T wave changes [18, 19] . Bosch et al. [18] found that 164 of 449 (37%) patients developed early post-myocardial infarction angina. Inhospital infarct extension occurred in 28% of patients with early post-infarction angina with ST-T changes, 3·5% of patients with post-infarction angina without ST-T changes, and 2·0% of patients without post-infarct angina (P<0·0001).
Baseline characteristics predictive of death, myocardial infarction, rest ischaemia or a positive risk-stratifying test
Our study demonstrated that patients with prior clinical manifestations of angina, i.e. preceding the presenting episode of unstable angina, and a family history of premature coronary disease were at significantly increased risk of developing a markedly positive exercise test or stress thallium study and that angina prior to the index acute ischaemic event was associated with increased short-term risk of an adverse cardiac outcome.
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Different anginal patterns have been associated with a progressively more adverse prognosis from stable angina to progressive angina to progressive angina accompanied by nocturnal angina, to frank unstable angina [19] . New onset, or rapidly progressive unstable angina in particular, has been associated with increased risk by most investigators [16, 20] , perhaps because these patients may have a ruptured plaque which is unstable and in jeopardy of leading to total coronary occlusion.
The adverse risk associated with the use of heparin prior to the qualifying anginal episode in our study undoubtedly reflects the marked instability of these patients since their qualifying anginal episode represented a 'failure' of an already intense medical regimen. Similarly, the adverse risk associated with prior aspirin use was most likely due to the presence of pre-existent coronary disease in those patients treated with aspirin, with aspirin therapy having been initiated before the index acute ischaemic syndrome probably because of prior coronary manifestations.
We found older age to be a predictor of an adverse clinical outcome, as well as of a markedly abnormal exercise test, stress thallium test and Holter. Previous investigators have consistently demonstrated that advanced age is the most important independent risk indicator for mortality in patients with stable coronary disease and acute myocardial infarction [21] [22] [23] [24] [25] .
Unique prognostic contribution of each risk stratifying test
A substantial number of patients were identified to be at high risk on the basis of a single test result: 34% of patients defined as high risk were only identified by the thallium test results, and 33% of patients at high risk were identified by the exercise test alone. However, the Holter contributed little independent prognostic information in these patients. A negative or mildly abnormal risk stratifying test early after presentation did not accurately predict lack of a marked abnormality on one of the other tests. Thus, a 'false-negative' test occurred in 21% of patients based on the thallium test, 23% based on the exercise test, and 43% based on the Holter.
Analysis of risk based on nature and number of baseline risk characteristics present
The powerful relationship between the nature and number of baseline risk characteristics present (STsegment depression on the qualifying ECG, history of prior angina, family history of premature coronary disease, prior use of heparin or aspirin, and older age) and 'failure' of conservative therapy (Fig. 1) In contrast, patients who have at least one risk characteristic, especially the presence of ST-segment depression on presentation, or those whose rest angina occurs despite heparin therapy, have a significantly increased chance of developing a cardiac event or a markedly abnormal risk stratifying test, and may be appropriate candidates for a more invasive therapeutic approach. The odds of failing medical therapy if STsegment depression alone is present is 2·6-5·9 times higher than if ST-segment depression is not present, and the odds of failing medical therapy if an episode of rest angina develops while on heparin therapy is 1·6-2·0 times that of patients not on heparin ( Table 3 ). The odds ratio of failing medical therapy if ST-segment depression is present on admission is so substantial that cardiac catheterization and revascularization are probably justified on the basis of its presence alone.
The presence of multiple risk characteristics provides even more compelling evidence to support an early strategy of expeditious catheterization. Figure 1 underscores the progressive nature of the relationship between increases in the number of risk characteristics present on admission and increases in the incidence of failing medical therapy. If three or more risk characteristics are present, the incidence of a clinical event or development of a strongly positive risk-stratifying test is greater than 50%. Certainly cardiac catheterization or transfer to a hospital with facilities for catheterization and revascularization is warranted in such patients, unless contraindications to revascularization are present. On the other hand, if less than three risk characteristics are present, then the incidence of failure of medical therapy is less than 50% and it may be possible to continue medical therapy and defer catheterization until after risk-stratifying tests are performed. The threshold of the specific number of risk characteristics present that trigger early initiation of an invasive approach can now be determined by the physician and patient based on the objective data presented here. In certain circumstances the risk of developing a clinical event or a markedly abnormal risk-stratifying test may be considered acceptable to both patient and physician and medical management may continue, followed by risk-stratifying tests; in other circumstances the risk may be unacceptable and early catheterization may be pursued.
The TIMI IIIB Study [1] found that a strategy of expeditious catheterization and revascularization does not improve morbidity or mortality in patients with unstable angina or non-Q wave myocardial infarction, an observation confirmed by the Veterans Affairs Non-Q-wave Infarction Strategies in Hospital (VANQWISH) trial [26] of patients with non-Q wave myocardial infarction. Nevertheless, TIMI IIIB demonstrated that an early invasive strategy does reduce utilization of medical resources: length of initial hospitalization, less frequent rehospitalization and fewer days of rehospitalization within 6 weeks, and less use of antianginal medications after discharge. If adverse cardiac risk could be identified early in the hospital course, using factors as we describe, then appropriate triage to a more invasive or more conservative management strategy could be implemented early. The net gains in resource utilization from efficient triage may be substantial.
It should be emphasized that the patients included in TIMI IIIB constitute a selected subset of all patients presenting with unstable angina or non-Q wave myocardial infarction. Additional Studies will need to address the generalizability of our findings to other patient subsets with these acute coronary syndromes.
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